HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduction in blood pressure and vascular reactivities to pressor substances by chronic treatment with piretanide in spontaneously hypertensive rats.

Abstract
1. Effects of treatment with piretanide (10 and 30 mg/kg per day p.o.) for 9 weeks on blood pressure, urinary excretion of electrolytes, and vascular reactivities to pressor substances were investigated in 10-week-old spontaneously hypertensive (SHR) rats. 2. Piretanide (30 mg/kg) prevented development of hypertension and produced a significant reduction in blood pressure from the 2nd week of the treatment. A slight decrease in blood pressure was observed in rats treated with the lower dose of piretanide. 3. Piretanide produced significant and dose-dependent diuresis throughout the experiment. Although significant natriuresis was observed in the 1st and 4th week of the treatment, natriuresis disappeared in the 8th week. Urinary excretion of potassium was decreased significantly by piretanide throughout the experiment. 4. Attenuation of pressor responses to phenylephrine and angiotensin II was observed after chronic administration of piretanide (30 mg/kg). 5. These data demonstrate the contribution of attenuated vascular reactivities to pressor substances as well as a diuretic action to the antihypertensive effect of piretanide during its long-term administration in SHR rats.
AuthorsK Kawashima, T Hayakawa, H Oohata, K Fujimoto, T Suzuki
JournalGeneral pharmacology (Gen Pharmacol) Vol. 20 Issue 2 Pg. 213-7 ( 1989) ISSN: 0306-3623 [Print] England
PMID2653950 (Publication Type: Journal Article)
Chemical References
  • Sulfonamides
  • Angiotensin II
  • Sodium
  • piretanide
  • Renin
  • Potassium
Topics
  • Angiotensin II (pharmacology)
  • Animals
  • Blood Pressure (drug effects)
  • Diuresis (drug effects)
  • Hemodynamics (drug effects)
  • Male
  • Potassium (urine)
  • Rats
  • Rats, Inbred SHR
  • Renin (blood)
  • Sodium (urine)
  • Sulfonamides (pharmacology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: